MNOV - メディシノバ (MediciNova Inc.) メディシノバ

 MNOVのチャート


 MNOVの企業情報

symbol MNOV
会社名 Medicinova Inc (メディシノバ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 メディシノバ(MediciNova Inc.)は主に米国市場を中心とした疾患の治療のための小分子治療薬を取得・開発するバイオ製薬企業である。同社の主要製品はMN-166(ibudilast)、MN-001(tipelukast)、MN-221(bedoradrine)、MN-029(denibulin)等がある。MN-166は経口で、抗炎症薬および神経保護剤であり、進行性多発性硬化症、筋萎縮性側索硬化症、物質依存および中毒などの神経的疾患の治療薬を開発する。MN-001(tipelukast)は非アルコール性脂肪性肝炎と特発性肺線維症などの線維性疾患を治療する経口の低分子化合物である。MN-221は静脈内注入で喘息の急性増悪を治療する。MN-029固形腫瘍癌を治療する。   メディシノバは、米国のバイオ医薬品企業。多発性硬化症、薬物依存、非アルコ―ル性脂肪性肝炎(NASH)、肺線維症、神経因性疼痛薬、慢性閉塞性肺疾患(COPD)、筋萎縮性側索硬化症(ASL)、気管支喘息急性発作などに対する治療薬の開発、商業化に従事。本社はカリフォルニア州。   MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market. MediciNova's current strategy is to focus on MN-166 (ibudilast) for neurological disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), degenerative cervical myelopathy (DCM), substance dependence (e.g., alcohol use disorder, methamphetamine dependence, opioid dependence) and glioblastoma (GBM), as well as prevention of acute respiratory distress syndrome (ARDS) caused by COVID-19, and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). MediciNova's pipeline also includes MN-221 (bedoradrine) and MN-029 (denibulin).
本社所在地 4275 Executive Square Suite 300 La Jolla CA 92037 USA
代表者氏名 Jeffrey Himawan ジェフリー・ヒマワン
代表者役職名 Independent Chairman of the Board
電話番号 +1 858-373-1500
設立年月日 36770
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 9人
url www.medicinova.com
nasdaq_url https://www.nasdaq.com/symbol/mnov
adr_tso
EBITDA EBITDA(百万ドル) -15.23832
終値(lastsale) 11.66
時価総額(marketcap) 488309991.18
時価総額 時価総額(百万ドル) 431.77330
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 367.61052
当期純利益 当期純利益(百万ドル) -13.74516
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 MediciNova Inc. revenues was not reported. Net loss increased 32% to $7.7M. Higher net loss reflects Research and development and patents increase of 69% to $3M (expense) General and administrative increase of 25% to $5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.17 to -$0.19.

 MNOVのテクニカル分析


 MNOVのニュース

   The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs  2021/07/15 12:07:56 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) - U.K. antitrust regulators cleared its pending acquisition by AstraZeneca PLC (NASDAQ: AZN ) Bristol-Myers Squibb Company (NYSE: BMY ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Moderna, Inc. (NASDAQ: MRNA ) PLx Pharma Inc. (NASDAQ: PLXP ) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) ( announced a registered direct offering) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) AlloVir, Inc. (NASDAQ: ALVR ) Aptose Biosciences Inc. (NASDAQ: APTO ) Avenue Therapeutics, Inc.
   The Daily Biotech Pulse: Lilly, Morphic''s Positive Data At ECCO, Humanigen''s COVID Treatment Gets Expedited Review In UK, TransCode IPO  2021/07/09 11:36:16 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO ) ( moved on positive analyst action) Ambrx Biopharma Inc. (NYSE: AMAM ) AtriCure, Inc. (NASDAQ: ATRC ) Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Edwards Lifesciences Corporation (NYSE: EW ) Novo Nordisk A/S (NYSE: NVO ) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 8) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) ADMA Biologics, Inc. (NASDAQ: ADMA ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) (announced positive Phase 2 data for non-alcoholic steatohepatitis drug) Allogene Therapeutics, Inc.
   MediciNova secures new U.S. patent for MN-166 in ophthalmic disease; shares up 9%  2021/07/06 10:44:21 Seeking Alpha
   MediciNova plans mouse study of MN-166 in chlorine gas-induced lung injury  2021/06/28 13:18:23 Seeking Alpha
   MediciNova To Test Ibudilast In BARDA''s Validated Mouse Model Of Chlorine-Induced Pulmonary Injury  2021/06/28 12:37:44 Benzinga
MediciNova Inc (NASDAQ: MNOV ) will conduct a mouse study to investigate the efficacy of MN-166 (ibudilast) in a murine model of chlorine-induced lung injury and lethality. After mice are exposed to chlorine gas and treated with MN-166 (ibudilast) or control, the study will evaluate survival, clinical outcomes, body weights, lung weights, and upper Full story available on Benzinga.com
   The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link  2021/03/10 12:25:58 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 9) Amneal Pharmaceuticals, Inc. (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC ) ( announced a new-gen multi-cancer detection sensor) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) Bausch Health Companies Inc. (NYSE: BHC ) (issued a pipeline update at a conference) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Cullinan Oncology, Inc. (NASDAQ: CGEM ) Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS ) (reacted to its fourth-quarter results) Second Sight Medical Products, Inc. (NASDAQ: EYES ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Surmodics, Inc. (NASDAQ: SRDX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 9) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) (moved lower in reaction to FDA communication regarding deficiencies in its regulatory application for dementia drug) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus MediciNova Gets BARDA Contract to Study MN-166 For Chlorine Gas-induced Lung Damage MediciNova, Inc. (NASDAQ: MNOV ) said it has partnered with the BARDA to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.
   31 Stocks Moving in Wednesday's Pre-Market Session  2021/03/10 12:19:45 Benzinga
Gainers MediciNova, Inc. (NASDAQ: MNOV ) shares rose 79.6% to $10.20 in pre-market trading after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas. Exela Technologies, Inc. (NASDAQ: XELA ) rose 72.9% to $7.97 in pre-market trading. Exela Technologies shares jumped 179% on Tuesday after the company said it won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer. Obalon Therapeutics, Inc. (NASDAQ: OBLN ) rose 50% to $5.31 in pre-market trading after climbing 18% on Tuesday. Atossa Therapeutics, Inc. (NASDAQ: ATOS ) shares rose 40.3% to $3.48 in pre-market trading after gaining over 16% on Tuesday. Atossa Therapeutics, last month, announced final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently diagnosed with COVID-19..
   Why MediciNova Shares Jumped 111% Today  2021/03/10 02:02:37 Benzinga
MediciNova, Inc (NASDAQ: MNOV ) … Full story available on Benzinga.com
   The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study  2021/03/03 12:46:17 Benzinga
Here's a roundup of top developments in … Full story available on Benzinga.com
   MediciNova Earnings and Growth Analysis : Stock market Insights & financial analysis  2021/03/01 19:35:00 Stock Market Daily
MediciNova announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link  2021/03/10 12:25:58 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 9) Amneal Pharmaceuticals, Inc. (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC ) ( announced a new-gen multi-cancer detection sensor) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) Bausch Health Companies Inc. (NYSE: BHC ) (issued a pipeline update at a conference) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Cullinan Oncology, Inc. (NASDAQ: CGEM ) Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS ) (reacted to its fourth-quarter results) Second Sight Medical Products, Inc. (NASDAQ: EYES ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Surmodics, Inc. (NASDAQ: SRDX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 9) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) (moved lower in reaction to FDA communication regarding deficiencies in its regulatory application for dementia drug) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus MediciNova Gets BARDA Contract to Study MN-166 For Chlorine Gas-induced Lung Damage MediciNova, Inc. (NASDAQ: MNOV ) said it has partnered with the BARDA to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.
   31 Stocks Moving in Wednesday's Pre-Market Session  2021/03/10 12:19:45 Benzinga
Gainers MediciNova, Inc. (NASDAQ: MNOV ) shares rose 79.6% to $10.20 in pre-market trading after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas. Exela Technologies, Inc. (NASDAQ: XELA ) rose 72.9% to $7.97 in pre-market trading. Exela Technologies shares jumped 179% on Tuesday after the company said it won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer. Obalon Therapeutics, Inc. (NASDAQ: OBLN ) rose 50% to $5.31 in pre-market trading after climbing 18% on Tuesday. Atossa Therapeutics, Inc. (NASDAQ: ATOS ) shares rose 40.3% to $3.48 in pre-market trading after gaining over 16% on Tuesday. Atossa Therapeutics, last month, announced final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently diagnosed with COVID-19..
   Why MediciNova Shares Jumped 111% Today  2021/03/10 02:02:37 Benzinga
MediciNova, Inc (NASDAQ: MNOV ) … Full story available on Benzinga.com
   The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study  2021/03/03 12:46:17 Benzinga
Here's a roundup of top developments in … Full story available on Benzinga.com
   MediciNova Earnings and Growth Analysis : Stock market Insights & financial analysis  2021/03/01 19:35:00 Stock Market Daily
MediciNova announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 メディシノバ MNOV MediciNova Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)